Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.4061/2010/647147 19 WillardFSDourosJDGabeMBNShowalterADWainscottDBSuterTMet al
Yang CT, Yao WY, Yang CY, Peng ZY, Ou HT, Kuo S
The package supports a variety of effect measures, including the odds ratio, risk ratio, risk difference, mean difference, and standardized mean difference
Notable Studies: Efficacy and safety of liraglutide 3.0 mg in patients with overweight and obese with or without diabetes: a systematic review and meta-analysis Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis Also Known As: Victoza, Saxenda, Xultophy, NN2211, GTPL1133 Research Applications: Weight loss Metabolic syndrome PCOS Neuroprotection Risks: Nausea and gastrointestinal upset Injection site reactions Tachycardia Potentially pancreatitis and neoplasias FDA approval limited to T2D and overweight/obese patients Chemical Structure What is Liraglutide
It remains in clinical trials and is still undergoing rigorous research and safety testing
US$ 22.28
US$ 27.29
US$ 24.35
US$ 20.50
US$ 26.06
